Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.17, ...
Pulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Pulse Biosciences (NASDAQ:PLSE – Free Report) to a sell rating in a report released on ...
Charles Schwab Investment Management Inc. Acquires 1,092 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE)
Charles Schwab Investment Management Inc. lifted its holdings in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE – Free Report ...
Morningstar9d
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates ...
Business Wire29d
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology ...
Investing1mon
Pulse Biosciences at TD Cowen Conference: nsPFA Technology Focus
On Wednesday, March 5, 2025, Pulse Biosciences (NASDAQ: PLSE) presented at the TD Cowen 45th Annual Healthcare Conference, highlighting its cutting-edge nanosecond Pulsed Field Ablation (nsPFA) ...
Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript
Pulse Biosciences, Inc. ( NASDAQ: PLSE) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Philip Trip Taylor - Investor Relations Paul LaViolette - Chief Executive Officer and Co-Chairman of ...
Q4 2024 Pulse Biosciences Inc Earnings Call
Philip Taylor; Investor Relations; Pulse Biosciences Inc. Paul Laviolette; Co-Chairman of the Board, President, Chief Executive Officer; Pulse Biosciences Inc. Jon S ...